-+ 0.00%
-+ 0.00%
-+ 0.00%

Conexeu Sciences Begins Early-Stage Development of Two Wound-Care Scaffold Formats

PUBT·11/17/2026 13:33:12
Listen to the news
Conexeu Sciences Begins Early-Stage Development of Two Wound-Care Scaffold Formats
  • Conexeu Sciences began early-stage development of W.A.F.E.R. Sheet and Lattice, fabricated collagen scaffolds extending its investigational CXU wound-care platform.
  • Sheet targets broad wound surfaces; Lattice is designed for large volumetric defects.
  • Neither format has undergone preclinical evaluation; initial work focuses on reproducible fabrication and characterization of structural and handling properties.
  • The lead flowable CXU candidate remains on track for a planned FDA 510(k) submission in the first quarter of 2027, pending required work.
  • W.A.F.E.R. formats are excluded from that submission and will follow separate development and regulatory pathways.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Conexeu Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611170830PRIMZONECNPR____9879168) on November 17, 2026, and is solely responsible for the information contained therein.